Quick Links


Home > Industry > Life Sciences > Biotech


Our Approach

Biotechnology companies face significant challenges as they seek to push the performance envelope and maintain continual innovation while operating within a strictly scrutinized regulatory environment. Armanino's deep experience in technology and biotech manufacturing gives us insight into industry best practices, allowing us to help companies maintain compliance, maximize available funds for R&D, minimize time to market and increase profits so they can grow their business and outperform global competition.

What We Do

Our experienced team of CPAs, former CFOs and industry operations and supply chain experts helps biotechnology companies find the smartest audit, tax, consulting and technology solutions for their operational and strategic needs. We help companies at all growth stages maximize their efficiency and build their business.


We can organize an efficient and cost-effective audit or review, ensuring that financial statements display accurate and meaningful results. Our services include:

  • Financial statement audits and reviews
  • Agreed-upon procedures
  • Equity accounting
  • Technical accounting guidance
  • SEC filings and disclosures
  • IFRS adoption/transition
  • Transfer pricing
  • SOX 404 compliance
  • Internal control evaluations for minimizing risk
  • Automation of revenue recognition
  • Internal project tracking for R&D
  • Enabling customer entitlement and product warranty/maintenance tracking
  • Automation of order-to-cash processes
  • Process re-engineering
  • Best practices for policies and procedures


We have extensive experience with the complex tax issues that impact biotechnology companies in the United States and abroad. Our tax experts provide filing guidance and help clients address key concerns and identify strategic tax-planning opportunities. Our services include:

  • Tax provision consulting/FIN 48
  • International tax and transfer pricing
  • Tax compliance
  • State and local tax
  • Loan staffing
  • Stock option accounting (123R) and complex tax data analysis
  • Tax process design
  • R&D credit studies, implementations, reviews and updates
  • IRS audit support
  • Net operating loss limitation analysis (Section 382)
  • Mergers and acquisitions
  • Expatriate tax services
  • IP offshore planning for tax minimization


Your biotech business is already awash in data. It’s time to exploit it effectively. Armanino helps you achieve compliance and identify the right analytics to meet strategic business objectives with our ERP, CRM, business intelligence, equity management, and budgeting and forecasting solutions. We also recommend streamlined business processes to accelerate the development and monetization of new products and reduction of operational costs. Learn more about Armanino’s biotechnology industry consulting expertise.


Biotech Firm Relies on Armanino to Determine Value at Critical Milestones

With help from Armanino, Principia delivers financial statements that include an objective, third-party valuation that both the company and its investors can stand behind.

Yellow Calendar Thumbnail
Make sure you don’t miss any important 2018 tax deadlines. Be aware that some deadlines have been moved up or pushed back compared to previous years.

Compare and Contrast the House and Senate Tax Bills

The House Ways and Means Committee amended, and approved, the Tax Cuts and Jobs Act, and the Senate Finance Committee released “policy highlights” for its proposed version of a tax plan.

Yellow Calendar Thumbnail
This summary of when various tax-related forms, payments and other actions are due will help you make sure you don’t miss any important 2017 tax deadlines.
Man Holding Stop Watch On Track Thumbnail

The new-and-improved revenue recognition GAAP rules go live in 2018 for calendar-year public companies. The time to begin implementation is upon us.

Kid Dressed As Pilot Against Bar Chart

Your guide to avoiding risk and simplifying the CRM evaluation and implementation process.

How Should the SEC Define “Accredited Investors”?

Investors and private businesses are at odds over who can invest in unregistered offerings. A recent SEC report explores the options in conflict.

There’s No Going Back: Employee Share-Based Payment Accounting

On March 30, FASB published ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting, which amends ASC 718. We discuss the changes and why you should partner with an expert.

Stethoscope Laying on Bar Graphs Thumbnail

Employers with medical reimbursement plans need to review them to ensure they don’t accumulate heavy tax penalties from noncompliance with Affordable Care A ...

Crystal Rock On Black Background Thumbnail

As the SEC requirements for conflict minerals disclosure tighten in 2015, high-tech companies need to strengthen their vendor audit systems.

Victorian Painted Ladies Thumbnail

California’s new filing requirement for like-kind property exchanges made under IRC Section 1031 covers like-kind exchanges that occur in tax years beginnin ...

Businesses, Individuals Benefit from Latest Tax Relief Extender Law

On Dec. 16, the Senate passed the Tax Increase Prevention Act of 2014 (TIPA), a stopgap measure that retroactively extends certain tax relief provisions through Dec. 31, 2014.

Walking Your Board Through a 409A Allocation of Total Equity Value

To avoid expensive tax liability for your privately-funded company, and more importantly, your employees, ensure your Board of Directors has the tools to properly understand the valuation process.

PowerView for Microsoft Dynamics AX

  trends and insights